Table 3.
Group 1: sepsis = reference | Group 2: infection HR [95% CI] | Group 2 versus 1: Wald p value | Group 3: inflammatory condition HR [95% CI] | Group 3 versus 1: Wald p value | |
---|---|---|---|---|---|
Cox regression of 3-year mortality | |||||
Crude | 1 [1–1] | 1.01 [0.97–1.07] | 0.5710073 | 0.68 [0.65–0.72] | < 0.001 |
Cox regression of 3-year mortality | |||||
Adjusted for chronic comorbidity | 1 [1–1] | 0.97 [0.92–1.02] | 0.2538482 | 0.83 [0.79–0.88] | < 0.001 |
Cox regression of 3-year mortality | |||||
Adjusted for APACHE-IV probability | 1 [1–1] | 1.03 [0.98–1.08] | 0.3251795 | 0.68 [0.65–0.72] | < 0.001 |
Cox regression of 3-year mortality | |||||
Adjusted for chronic comorbidities and APACHE-IV probability | 1 [1–1] | 0.98 [0.93–1.03] | 0.3616948 | 0.83 [0.78–0.88] | < 0.001 |
Cox regression of 3-year mortality | |||||
Adjusted for chronic comorbidities, APACHE-IV probability, mechanical ventilation, acute renal failure, vasoactive drugs | 1 [1–1] | 1 [0.95–1.05] | 1 | 0.88 [0.83–0.94] | < 0.001 |
Chronic comorbidities includes: cardiovascular insufficiency, chronic respiratory insufficiency, renal insufficiency, malignancy, immuno-deficiency, cirrhosis